Skip to content

Progyny PGNY Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

CVS Health logo
CVS HealthCVS
$103M-28.5%
UnitedHealth Group logo
UnitedHealth GroupUNH
$231M-35.8%
Natera, Inc. logo
Natera, Inc.NTRA
$3.86M+610%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$1.22M+234%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$774K-65.5%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
$544K-17.8%

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's stock issuance proceeds?
Progyny (PGNY) reported stock issuance proceeds of $30K in Q1 2026.
How has Progyny's stock issuance proceeds changed year-over-year?
Progyny's stock issuance proceeds decreased by 23.1% year-over-year, from $39K to $30K.
What is the long-term trend for Progyny's stock issuance proceeds?
Over 3 years (2021 to 2024), Progyny's stock issuance proceeds has grown at a -27.8% compound annual growth rate (CAGR), from $2.92M to $1.1M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.